Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

被引：0

作者：

Yogesh Suresh Punekar

Sarah H Landis

Keele Wurst

Hoa Le

机构：

[1] Value Evidence and Outcomes,

[2] GlaxoSmithKline Stockley Park,undefined

[3] Worldwide Epidemiology,undefined

[4] GlaxoSmithKline R&D,undefined

[5] Former employee of GlaxoSmithKline R&D,undefined

[6] RTP,undefined

[7] Former employee of Parexel International,undefined

[8] RTP,undefined

来源：

Respiratory Research | / 16卷

关键词：

COPD; Costs; Long-acting bronchodilators; Primary care; Resource use; Retrospective cohort study; UK;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 99 条

[41]

Heaney LG(undefined)undefined undefined undefined undefined-undefined

[42]

Blanchette CM(undefined)undefined undefined undefined undefined-undefined

[43]

Gross NJ(undefined)undefined undefined undefined undefined-undefined

[44]

Altman P(undefined)undefined undefined undefined undefined-undefined

[45]

Simon-Tuval T(undefined)undefined undefined undefined undefined-undefined

[46]

Maimon N(undefined)undefined undefined undefined undefined-undefined

[47]

Penning-van Beest F(undefined)undefined undefined undefined undefined-undefined

[48]

van Herk-Sukel M(undefined)undefined undefined undefined undefined-undefined

[49]

Gale R(undefined)undefined undefined undefined undefined-undefined

[50]

Lammers JW(undefined)undefined undefined undefined undefined-undefined